Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Drawing on related knowledge to advance multiple sclerosis falls-prevention research.
Multiple Roles for Nogo Receptor 1 in Visual System Plasticity.
No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis.
Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?
Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
A pilot study on factors involved with work participation in the early stages of multiple sclerosis.
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis.
Vivax malaria presenting with myelitis: a rare complication.
Management of multiple sclerosis.
Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy.
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.
Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective.
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice.
Correction: Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Disease-modifying agents in multiple sclerosis.
The Disease-Ameliorating Function of Autoregulatory CD8 T Cells Is Mediated by Targeting of Encephalitogenic CD4 T Cells in Experimental Autoimmune Encephalomyelitis.
LINGO-1 Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments.
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review.

Pages